Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Therapeutische Umschau. Revue Therapeutique|October 5, 2011
[Sarcomas and mixed mesodermal tumors of the uterus]Andreas R Günthert
Advances in Experimental Medicine and Biology|July 22, 2008
Hormonal heterogeneity of endometrial cancerCarsten Gründker, Andreas R Günthert, Günter Emons
European Journal of Endocrinology|December 26, 2001
Biology of the gonadotropin-releasing hormone system in gynecological cancersCarsten Gründker, Andreas R Günthert, Silke Westphalen, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cellsAndreas R Günthert, Carsten Gründker, Kirsten Hollmann, et al.
Anticancer Research|July 28, 2004
Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cellsAndreas R Günthert, Carsten Gründker, Bettina Böttcher, et al.
International Journal of Oncology|October 4, 2006
GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cellsNicola Eicke, Andreas R Günthert, Günter Emons, et al.
European Journal of Endocrinology|November 13, 2004
Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cellsCarsten Gründker, Andreas R Günthert, Martin Hellriegel, et al.
Frontiers in Medicine|January 21, 2017
Acellular Dermal Matrix (Permacol®) for Heterologous Immediate Breast Reconstruction after Skin-Sparing Mastectomy in Patients with Breast Cancer: A Single-Institution Experience and a Review of the LiteratureLaura Knabben, Gowthami Kanagalingam, Sara Imboden, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 7, 2021
Outcome of perineoplasty and de-adhesion in patients with vulvar Lichen sclerosus and sexual disordersFabienne Lauber, Inês Vaz, Jörg Krebs, et al.
Cancer Research|February 20, 2007
Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivoStefanie Fister, Andreas R Günthert, Günter Emons, et al.
Pageof 4